The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

BRS working president K T Rama Rao alleged that the police department is working like a private army of the Chief Minister to ...

Indian markets fell for the sixth consecutive session due to weak global trends, a rising dollar index, and foreign investor selling. The Sensex dropped 266 points to 77,424.81, while the Nifty lost ...

It attributed the downturn to the July-August mass upsurge, labour unrest, and prolonged flooding, which significantly impacted operations and distribution channels.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

Norway equities were higher at the close on Thursday, as gains in the Healthcare Equipment & Services, Pharma Biotech & Life ...

Many companies have already adopted the rules, which become binding Nov. 20. But while regulators were drafting them, a new ...

Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

On Wednesday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.17 or 0.69% from the prior close of $24.62. The stock opened at ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...